Al-Bakoush: Libya is contracted to receive 2 million vaccine doses

The 2 million procured doses will be primarily for those most vulnerable to the virus

Libya to procure vaccine doses for those most in need. [Photo: Internet/Arhcives]
The Head of the Advisory Committee to Confront the Coronavirus Pandemic, Khalifa Al-Bakoush, confirmed that Libya has contracted with the COVAX facility to get two million doses of the Coronavirus vaccine as soon as it is made available. 

The Head of the Advisory Committee has clarified in a statement prior that the vaccine that will be supplied will not be made available to all the Libyan people immediately, but will be confined in the first stage to the most vulnerable groups to the virus, such as doctors, medical staff, elderly people and those with chronic illnesses.

64 higher-income nations have joined the COVAX Facility, which is Co-led by the Vaccine Alliance and World Health Organization to bring together governments and manufacturers to ensure eventual COVID-19 vaccines reach those in greatest need, whoever they are and wherever they live, regardless of their economic situation.

The number of Covid-19 cases in Libya has been seeing a steady increase over the last few months, with the country’s total number of cases surpassing 82 thousand as of this week, however, doctors reassure citizens that the number of recovered patients exceeds the number of infected cases, with over 53 thousand cases that have recovered fully from the virus.

The views expressed in Op-Ed pieces are those of the author and do not purport to reflect the opinions or views of Libyan Express.
How to submit an Op-Ed: Libyan Express accepts opinion articles on a wide range of topics. Submissions may be sent to Please include ‘Op-Ed’ in the subject line.
You might also like

Submit a Correction

For: Al-Bakoush: Libya is contracted to receive 2 million vaccine doses

Your suggestion have been successfully submitted

There was an error while trying to send your request. Please try again.

Libyan Express will use the information you provide on this form to be in touch with you and to provide updates and marketing.